Is vaginal progesterone treatment associated with the development of gestational diabetes? A retrospective case-control study.

Klara RostaJohannes OttFanni KelemenWilhelm TemschTobias LahnerTheresa ReischerHanns HelmerAniko Somogyi

Published in: Archives of gynecology and obstetrics (2018)

The use of vaginal progesterone for the prevention of recurrent preterm delivery and in women with a short cervix does not seem to be associated with an increased risk of GDM.

Keyphrases

preterm birth
estrogen receptor
low birth weight
gestational age
preterm infants